Wisconsin Medical Journal

Ms Perfetti and Dr Clark are with the University of Wisconsin Medical School. Doctor Fillmore is with the Medical College of Wisconsin. Please address correspondence to Roseanne Clark, PhD, Department of Psychiatry, University of Wisconsin Medical School, 6001 Research Park Blvd, Madison, WI 53719; phone 608.263.6067; fax 608.262.0265; e-mail [email protected]. ABSTRACT Depression during the postpartum period is a significant public health concern, affecting 8%-15% of women and resulting in considerable morbidity for women, and their infants and families. Risk, prevalence, and distinguishing features of postpartum mood disorders are provided. Anxiety and depression frequently co-occur, suggesting symptoms of anxiety should also be attended to when screening for postpartum depression. Recommendations include the use of a brief, valid screening instrument as a routine clinical practice and the unique role of the obstetrician/gynecologist, pediatrician, and family practice physician in identification and referral. A summary of evidence-based treatment options for postpartum depression, along with current information about psychotropic medication, is provided to assist in risk-benefit analyses and decision making with patients.